kpc

(redirected from Klebsiella pneumoniae carbapenemase)
Also found in: Medical, Encyclopedia.

kpc

kiloparsec.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
References in periodicals archive ?
CTX-M, active on cefotaxime first isolated in Munich; KPC, Klebsiella pneumoniae carbapenemase; NDM, New Delhi metallo-p-lactamases; OXA, active on oxacillin; QRDR, quinolone resistance determinants.
Frequency of Klebsiella pneumoniae carbapenemase (KPC)-producing and non-KPC-producing Klebsiella species contamination of healthcare workers and the environment.
carbapenemases, especially Klebsiella pneumoniae carbapenemase 2 (KPC-2) and more recently, New Delhi Metallo [beta]-lactamase 1 (NDM-1) (Rozales et al., 2014; Nordmann et al., 2011).
Other investigative therapies approved for adults and under study for use in children include ceftazidime/avibactam for treatment of urinary tract and complicated intra-abdominal infections, which is effective against meropenem-resistant Enterobacteriaceae and resistant Escherichia coli with extended-spectrum beta-lactamases (ESBL); ceftolozane/tazobactam, pending approval in pediatric patients, which is active against ESBLs such as Pseudomonas; and meropenem/vaborbactam, which is active against Klebsiella pneumoniae carbapenemase (KPC)-producing isolates.
The bug, klebsiella pneumoniae carbapenemase, can cause urinary tract infections and pneumonia.
In the United States, the carbapenemase most frequently identified among Enterobacteriaceae is Klebsiella pneumoniae carbapenemase; others are less common and are most often identified in patients who recently received health care outside the United States.
Emergence of New Delhi metallo-beta- lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa.
Synergistic effect was also observed when amikacin was combined with meropenem or imipenem against Klebsiella pneumoniae carbapenemase (KPC)-producing K.
Among the most worrisome CREs are the Gram-negative bacilli that produce Klebsiella pneumoniae carbapenemase (KPC), a broad-spectrum [beta]-lactamase.